Filing Details
- Accession Number:
- 0001144204-15-005665
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-03 18:51:09
- Reporting Period:
- 2015-01-30
- Filing Date:
- 2015-02-03
- Accepted Time:
- 2015-02-03 18:51:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887247 | Adamis Pharmaceuticals Corp | ADMP | Pharmaceutical Preparations (2834) | 820429727 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1506115 | Fazlur Shayan Ahmed Rahman | Sharjah Airport International Free Zone Executive Suite, P.o. Box 9366 Sharjah C0 00000 | No | No | Yes | No | |
1506117 | (Fze) Holdings Eses | Sharjah Airport International Free Zone Executive Suite, P.o. Box 9366 Sharjah C0 00000 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 | Disposition | 2015-01-30 | 10,000 | $6.92 | 1,705,388 | No | 4 | S | Indirect | See Footnote |
Common Stock, Par Value $0.0001 | Disposition | 2015-02-03 | 20,000 | $6.67 | 1,685,388 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Footnotes
- Represents shares of the Issuer's common stock held by Eses Holdings (FZE), a corporation organized under the laws of Sharjah, United Arab Emirates ("Eses"). Ahmed Shayan Fazlur Rahman is the sole shareholder of Eses, and possesses the power to vote and the power to direct the disposition of all securities of the Issuer held by Eses.
- Represents the sale of 20,000 shares in 5 separate transactions, ranging from $6.6192 to $6.7517 per share, resulting in a weighted average sale price per share of $6.6690. The Reporting Persons undertake to provide upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.